MDMA Crystal

Buy MDMA Crystal Online

• MDMA is a synthetic substance commonly known as ecstasy, although the latter term has now been generalized to cover a wide range of other substances.
• Originally developed in 1912 by the Merck chemical company, it was never marketed as such.
• Although proposed as an aid to psychiatric counseling, therapeutic use is extremely limited.
• Illicit it is normally seen as tablets, many of which are manufactured in Europe.
• It acts as a central nervous system (CNS) stimulant and has a weak hallucinogenic property more accurately described as increased sensory awareness.
• It is under international control.

Physical Forms:

• It has become widely known as ecstasy. Shortened “E”, “X”, or “XTC”.
• Usually referring to its tablet form, although this term may also include the presence of possible adulterants or dilutants.
• The UK term “mandy” and the US term “molly” colloquially refer to MDMA in a crystalline powder form that is thought to be free of adulterants.
• MDMA  in combination with other drugs such as alcohol or marijuana.
• It increases the activity of three brain chemicals:
• Dopamine causes a surge in euphoria and increased energy/activity
• Norepinephrine increases heart rate and blood pressure, which are particularly risky for people with heart and blood vessel problems-
• Serotonin affects mood, appetite, sleep, and other functions.
• It also triggers hormones that affect sexual arousal and trust.
• The release of large amounts of serotonin likely causes the emotional closeness, elevated mood, felt by the users.

Pharmacology:

• Whereas phenethylamines without ring substitution usually behave as stimulants, ring substitution (as in MDMA) leads to a modification in the pharmacological properties.
• Ingestion of it causes euphoria, increased sensory awareness, and mild central stimulation.
• It is less hallucinogenic than its lower homolog, methylenedioxyamphetamine (MDA).
• The terms empathogenic and entactogenic have been coined to describe the socializing effects.
• Following ingestion, most of the dose of it is excreted in the urine unchanged.
• Major metabolites are 3,4-methylenedioxyamphetamine (MDA) and O-demethylated compounds.
• Following a dose of 75 mg, the maximum plasma concentration of around 0.13 mg/L is reached within two hours.
• The plasma half-life is 6–7 hours.
• In animals, it causes neurotoxicity, as evidenced by anatomical changes in axon structure and a persisting reduction in brain serotonin levels.
• The significance of these findings to human users is still unclear, although cognitive impairment is associated with ecstasy use.
• Some of its pharmacodynamic and toxic effects of it vary, depending on which enantiomer is used. However, almost all illicit ecstasy exists as a racemic mixture.
• Fatalities following a dose of 300 mg have been noted, but toxicity depends on many factors, including individual susceptibility and the circumstances in which it is used.